TNIK inhibition abrogates colorectal cancer stemness
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Canonical Wnt/β-catenin signalling is essential for maintaining intestinal stem cells, and its constitutive activation has been implicated in colorectal carcinogenesis. We and others have previously identified Traf2- and Nck-interacting kinase (TNIK) as an essential regulatory component of the T-cell factor-4 and β-catenin transcriptional complex. Consistent with this, Tnik -deficient mice are resistant to azoxymethane-induced colon tumorigenesis, and Tnik −/− / Apc min/+ mutant mice develop significantly fewer intestinal tumours. Here we report the first orally available small-molecule TNIK inhibitor, NCB-0846, having anti-Wnt activity. X-ray co-crystal structure analysis reveals that NCB-0846 binds to TNIK in an inactive conformation, and this binding mode seems to be essential for Wnt inhibition. NCB-0846 suppresses Wnt-driven intestinal tumorigenesis in Apc min/+ mice and the sphere- and tumour-forming activities of colorectal cancer cells. TNIK is required for the tumour-initiating function of colorectal cancer stem cells. Its inhibition is a promising therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Identification of a novel TNIK inhibitor. (a) Structure of NCB-0846 (left) and its diastereomer NCB-0970 having the opposite configuration at the terminal hydroxyl group (right). (b) Inhibition of TNIK enzyme activity by the indicated concentration of NCB-0846 or NCB-0970. (c) Inhibitory profiles of NCB-0846 and NCB-0970 across the human kinome. The degree of inhibition is presented schematically by the size of the circles. (d) Inhibition of TCF4 phosphorylation by NCB-0846. The recombinant human TCF4 protein was incubated with the recombinant human TNIK protein in the presence of the indicated concentration of NCB-0846 or NCB-0970 and analysed by immunoblotting. (e) Inhibition of TNIK auto-phosphorylation by NCB-0846. HCT116 cells were cultured in the presence of DMSO (vehicle), 1 μM NCB-0846, or 1 μM NCB-0970 for 4 or 24 h and then analysed by immunoblotting with anti-phosphorylated TNIK, anti-TNIK, and anti-γ-tubulin (loading control) antibodies. (f) Suppression of TCF/LEF transcriptional activity by NCB-0846. HEK293 cells were transfected with pGL4.49[luc2P/TCF-LEF-RE/Hygro] and then treated with the indicated concentration of NCB-0846 or NCB-0970 for 24 h. The cells were then incubated with or without recombinant Wnt3a (10 ng ml−1) for 5 h before measurement of luciferase activity. Data are represented as ratios relative to the DMSO control (set at 100%)±s.e.m. (g) HCT116 (left) and DLD-1 (right) cells were transfected with one of the luciferase reporter plasmids (SuperTOP-flash or SuperFOP-flash) and then treated with 20 mM LiCl and the indicated concentration of NCB-0846 or NCB-0970 for 24 h. Data are presented as the ratios of SuperTOP-flash to SuperFOP-flash (TOP/FOP ratio). Error bars represent s.d. (h) HCT116 cells were treated with DMSO (control) or the indicated concentration of NCB-0846. Twenty-four hours later, the expression levels of the TNIK, AXIN2, CCND1 and MYC genes (normalized to ACTB) were quantified in triplicate by RT–PCR. The values of cells treated with DMSO were set to one. Error bars represent s.d. (i) HCT116 and DLD-1 cells were treated with DMSO (vehicle) or the indicated concentration of NCB-0846 or NCB-0970 for 48 h. The expression of TNIK, AXIN2, c-MYC, LRP6, LRP5 and β-actin (loading control) proteins was analysed by immunoblotting.](https://figures.cochat.ai/paper-figures/63ad699b11674e5794b145febc5ea025/tnik-inhibition-abrogates-colorectal-cancer-stemness-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cancer therapeutic development targeting the Wnt pathway is focused on downstream mediators including tumor necrosis factor receptor-associated factor (TRAF) and NCK-interacting protein kinase (TNIK), an essential regulator of the TCF4/β-catenin complex [110]”
From Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment (2024) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Cited by
Items 101–185 of 185
Luo, X., Yang, R., Li, Y., Zhang, L., Yang, S., & Li, L. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128745 · Cited by 10
Artificial intelligence in idiopathic pulmonary fibrosis: advances, challenges and future directions
Selman, M., Buendía-Roldán, I., & Pardo, A. (2025) · European Respiratory Journal · doi:10.1183/13993003.01112-2025 · Cited by 9
Overcoming Therapeutic Resistance in Triple-Negative Breast Cancer: Targeting the Undrugged Kinome
Lee, C. H., Nguyen, T. M., Lee, Y., Choi, S. G., Nguyễn, P. N., Park, J. H., & Park, M. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010450 · Cited by 9
Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancer
Teng, Y., Wu, R., Bo, W., Tang, M., Wang, T., Cui, X., Li, Y., Zhang, C., Ma, Z., Fu, Z., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116240 · Cited by 9
TNIK: A redox sensor in endothelial cell permeability
Joachim, J., Maselli, D., Petsolari, E., Aman, J., Swiatlowska, P., Killock, D., Chaudhry, H., Zarban, A. A., Sarker, M. H., Fraser, P. A., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk6583 · Cited by 9
TNIK drives castration-resistant prostate cancer via phosphorylating EGFR
Guo, J., Liang, J., Wang, Y., Guo, T., Liao, Y., Zhong, B., Guo, S., Cao, Q., Li, J., Flores‐Morales, A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108713 · Cited by 9
TNIK depletion induces inflammation and apoptosis in injured renal proximal tubule epithelial cells
Bradford, S. T. J., Wu, H., Kirita, Y., Chen, C., Malvin, N. P., Yoshimura, Y., Muto, Y., & Humphreys, B. D. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00262.2023 · Cited by 9
Sphéroïdes : le modèle de référence pour la culture in vitro des tumeurs solides ?
Larsen, C. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.09.008 · Cited by 9
Masuda, M., Nakagawa, R., & Kondo, T. (2024) · Cancer Science · doi:10.1111/cas.16123 · Cited by 8
Self-citationYu, P., Liu, D., Han, Z.-X., Liang, F., Hao, C.-Y., Lei, Y., Guo, C.-R., Wang, W., Li, X., Yang, X., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.779715 · Cited by 8
Utility of Reverse-Phase Protein Array for Refining Precision Oncology
Masuda, M., & Yamada, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9755-5_13 · Cited by 8
Self-citationALHulais, R. A., & Ralph, S. J. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.71 · Cited by 8
Pharmacologically Targeting the WNT/β-Catenin Signaling Cascade: Avoiding the Sword of Damocles
Lai, K. K. Y., & Kahn, M. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_523 · Cited by 7
TCF/LEF-mediated transcriptional regulation in the canonical Wnt pathway
Takano, C., & Higuchi, Y. (2025) · Current Molecular Pharmacology · doi:10.1016/j.cmp.2025.09.004 · Cited by 6
Tanimoto, A., Ramkumar, K., Stewart, C. A., Zhang, B., Concannon, K., Cardnell, R. J., Shen, L., Wang, Q., Wang, J., Gay, C. M., et al. (2025) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2025.12.102 · Cited by 6
Li, J., Lan, L., Xu, Y., Liu, S., Liu, M., Hu, G., Wu, G., Zhao, Y., Shi, J., Wang, J., et al. (2023) · Oncology Letters · doi:10.3892/ol.2023.13896 · Cited by 6
Miyako, S., Matsuda, T., Koma, Y., Koide, T., Sawada, R., Hasegawa, H., Yamashita, K., Harada, H., Urakawa, N., Goto, H., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11010174 · Cited by 6
Zhang, R., Yu, Y., Yang, Y., Zhang, M., Zhang, X., Chang, Y., Wang, S., Hu, L., Li, J., Zheng, X., et al. (2024) · Medical Oncology · doi:10.1007/s12032-024-02380-y · Cited by 6
Polyploid cardiomyocytes define disease-specific transcriptional states in the mammalian heartPreprint
Kießling, P., Joodaki, M., Pikulska, D., Scheidereit, E., Cesaro, G., Ruiz, M., Kühn, D., Peng, K., Goni, O., Foecking, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.31.701472 · Cited by 6
Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer
Puleo, N., Ram, H., Dziubinski, M. L., Carvette, D., Teitel, J., Sekhar, S. C., Bedi, K., Robida, A. M., Nakashima, M. M., Farsinejad, S., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0785 · Cited by 5
Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer
Kaida, T., Fujiyama, Y., Soeno, T., Yokota, M., Nakamoto, S., Goto, T., Watanabe, A., Okuno, K., Nie, Y., Fujino, S., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0277395 · Cited by 5
Long, X., Steurer, B., Wong, C. W., Kozlova, E., Naumov, V., Pun, F. W., Aliper, A., Ren, F., & Zhavoronkov, A. A. (2024) · Future Medicine AI · doi:10.2217/fmai-2023-0019 · Cited by 5
Mehta, C. C., Rohit, S., Patel, S., & Bhatt, H. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2175376 · Cited by 5
Mehta, C. C., Patel, A., & Bhatt, H. (2020) · Structural Chemistry · doi:10.1007/s11224-020-01583-z · Cited by 5
TNIK-driven regulation of ERK5 transcriptional activity in endothelial cells
Samanthapudi, V. S. K., Kotla, S., & Le, N.-T. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1526676 · Cited by 4
Zhao, L., Liu, H., Yao, X., Ma, X., Liu, B., Li, B., Tong, H. H. Y., & Zhang, Q. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01521 · Cited by 4
Tian, B., Ding, L., Li, S., Liu, J., Qiao, X., Ma, D., & Zhang, X. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.143341 · Cited by 4
van Os, B. W., Kusters, P. J. H., den Toom, M., Beckers, L., van Tiel, C. M., Vos, W. G., de Jong, E. A. M., Kieser, A., van Roomen, C. P. A. A., Binder, C. J., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1171764 · Cited by 4
Liu, G., Zhang, C., Wang, Y., Dai, G., Liu, S.-Q., Wang, W., Pan, Y.-H., Ding, J., & Li, H. (2021) · Placenta · doi:10.1016/j.placenta.2021.08.048 · Cited by 4
Naito, S., Fukushima, T., Endo, A., Denda, K., & Komada, M. (2020) · FEBS Letters · doi:10.1002/1873-3468.13769 · Cited by 4
Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma
Rai, S., Duns, G., Frontzek, F., Wong, J., Yin, Y., Li, M. Y., Kishida, M., Fujisawa, M., Healy, S., Viganò, E., et al. (2025) · Blood · doi:10.1182/blood.2025028412 · Cited by 3
Li, Y., Wang, F., Wang, K., Chen, G., Bai, L., Shi, J., & Yu, D. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108768 · Cited by 3
Weber, L. I., Timpen, L. E., Egger, A.-S., Schöpf, P., Ayhan, N. D., Demmel, D., Hotze, M., Zhang, Y., Mehrabi, M., Puglisi, K., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2524159123 · Cited by 3
Hamid, M., Siddig, A. M. A., Suliman, R., Saeed, A., Mussa, A., & Al-Hatamleh, M. A. I. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218665 · Cited by 3
Ngalim, S. H., Yusoff, N., Johnson, R. R., Razak, S. R. A., Chen, X., Hobbs, J. K., & Lee, Y. Y. (2022) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2022.09.003 · Cited by 3
TNIK regulation of interferon signaling and endothelial cell response to virus infection
Chau, K. M., Dominic, A., Davis, E. L., Kotla, S., Turcios, E. B., Fahim, A., Arunesh, A., Li, S., Zhao, D., Chen, K., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1213428 · Cited by 3
Ding, G., Yu, H., Jin, J. G., Qiao, X., Ma, J., Zhang, T., & Cheng, X. (2024) · Future Oncology · doi:10.2217/fon-2023-0907 · Cited by 3
Kanda, Y., Ohata, H., Miyazaki, T., Sakai, H., Mori, Y., Shiokawa, D., Yokoi, A., Owa, T., Ochiai, A., & Okamoto, K. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.11.063 · Cited by 3
Self-citationCircular RNA circTNIK promotes tumor progression and metastasis in gastric cancer by regulating ZEB2
Chen, N., Hu, Y., Huang, R., & Chen, D. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16189 · Cited by 3
Traf2- and Nck-interacting kinase inhibitors: a patent review (2008–2024)
Qin, L., Aladinskiy, V., Gennert, D. G., Cheng, X., Liu, J., Liu, T., Ren, F., & Zhavoronkov, A. A. (2025) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2025.2548585 · Cited by 2
Bagabir, S. A. (2023) · ChemistrySelect · doi:10.1002/slct.202300646 · Cited by 2
Jalnapurkar, B., Le, D., Shainin, W., Zarcone, R., Bhatnagar, R., Chin, J., Corbin, C. K., Curt, C., Hodge, B. A., Martinez, F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.21.568079 · Cited by 2
Edward, J., Sudarsha, K., Jeyakanthan, J., Rosita, A. S., & Gideon, D. A. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_52 · Cited by 1
Altered Wnt Pathway and Cancer Stem Cells
Mubashra, Srivastava, A., Shukla, A., Baptist, A. S., & Srivastava, S. (2024) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-74842-4_4 · Cited by 1
Targeting Wnt/β‐Catenin Pathway by DNA Alkylating Pyrrole‐Imidazole Polyamide in Colon Cancer
Shimozato, O., Akao, N., Yanagisawa, Y., Mori, Y., Zhang, X., Kida, Y., Igarashi, R., Watanabe, T., Ozaki, T., & Takatori, A. (2025) · Cancer Science · doi:10.1111/cas.70234 · Cited by 1
Mishra, D. K., Kumar, R., Baidya, A. T. K., Jangra, J., Misra, S. K., Kumar, S., & Kumar, A. (2026) · Talanta · doi:10.1016/j.talanta.2026.130342 · Cited by 1
Kumar, R., Dasgupta, P., Ray, S., & Paul, S. (2026) · The FASEB Journal · doi:10.1096/fj.202600627rr · Cited by 1
Zhang, Y., Vinogradov, A. A., Hamada, K., Sun, Y., Sengoku, T., & Suga, H. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.2417165 · Cited by 1
Micro-Inversions In Human Cancer Genomes
Li, Q., Zhu, H., & Wang, M. D. (2018) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2018.8512514 · Cited by 1
TNIK swaths AR to WNT pathway and drives Castration-Resistant Prostate CancerPreprint
Jiang, N., Guo, T., Wang, M., Liao, Y., Ma, F., Gao, J., Wang, Y., Wang, K., Wu, Y., Flores‐Morales, A., et al. (2020) · doi:10.21203/rs.3.rs-18207/v1 · Cited by 1
Nip, K. M. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0362390
Özkan, A. D., Haciefendi, A., Özkan, F., Eskiler, G. G., Kaleli, S., Çakmak, E. A., & Turna, Ö. (2022) · Online Türk Sağlık Bilimleri Dergisi · doi:10.26453/otjhs.1036628
Edward, J., Sudarsha, K., Jeyakanthan, J., Rosita, A. S., & Gideon, D. A. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_52-1
Tanimoto, A., Morris, B., Ramkumar, K., Cardnell, R. J., Shen, L., Wang, Q., Stewart, A., Gay, C. M., Wang, J., & Byers, L. A. (2022) · Leading Edge of Cancer Research Symposium · doi:10.52519/00089
Potential utility of reverse-phase protein array for refining precision cancer medicine
Masuda, M. (2022) · SEIBUTSU BUTSURI KAGAKU · doi:10.2198/electroph.66.31
Self-citationAudero, M. M. (2023) · theses.fr (ABES) · doi:10.70675/c7d3a910z1247z48fdzaac7zd22394945975
Chen, Y., Kassam, I., Lau, S. H., Kooner, J. S., Wilson, R., Peters, A., Winkelmann, J., Chambers, J. C., Chow, V. T. K., Khor, C. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16841289
Mécanismes ioniques dans l'adaptation tumorale
Folcher, A. (2023) · theses.fr (ABES) · doi:10.70675/04270336z7a70z430ez87ddz24d4d20241de
Özçelik, Ş., Hamarat, K. F., Eskiler, G. G., & Kaleli, S. (2024) · Sakarya Medical Journal · doi:10.31832/smj.1593181
Toward Combinatorial Strategies to Improve Proximal Tubule Recovery Following Acute Kidney Injury
Bastos, D. A., Oti, L. O., Ellis, C. L., & Bradford, S. T. J. (2025) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2025.151675
Yang, J., Luo, G., Li, C., Zhao, Z., Ju, S., Li, Q., Chen, Z., Ding, C., Tong, X., & Zhao, J. (2022) · Figshare · doi:10.6084/m9.figshare.19932974
Chen, Y., Kassam, I., Lau, S. H., Kooner, J. S., Wilson, R., Peters, A., Winkelmann, J., Chambers, J. C., Chow, V. T. K., Khor, C. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16841292
Yang, J., Luo, G., Li, C., Zhao, Z., Ju, S., Li, Q., Chen, Z., Ding, C., Tong, X., & Zhao, J. (2022) · Figshare · doi:10.6084/m9.figshare.19932980
Yang, J., Luo, G., Li, C., Zhao, Z., Ju, S., Li, Q., Chen, Z., Ding, C., Tong, X., & Zhao, J. (2022) · Figshare · doi:10.6084/m9.figshare.19932977
Harmantepe, A. T., Dikicier, E., Kocer, B., Kazan, N., & Yiğit, M. (2025) · Sakarya Medical Journal · doi:10.31832/smj.1762998
Niu, X., Zhang, S., Xu, B. Y., Deng, W., Zhang, X., He, H., Shi, X., Tong, M., chen, J., & Qin, M. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118717
T cells in cardiovascular disease:Dyslipidemia and checkpoints
van Os, B. W. (2023) · UvA-DARE (University of Amsterdam)
Chowdhury, D. D., Imada, E. L., Connis, N., Chang, J., Chan, A., Tseng, H. W., Lafargue, A. M., Carrieri, F. A., Nguyen, T., Waters, D. N., et al. (2026) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-25-0529
Subtype-specific prognostic impact of TNIK in medulloblastoma
Klaus, F., Maragkou, T., Delbridge, C., Eberhardt, C. G., Hewer, E., Gocke, A., Radpour, R., Mawrin, C., Mogler, C., Neumann, J. E., et al. (2026) · Journal of Neuro-Oncology · doi:10.1007/s11060-026-05554-y
DEFINING THE KINOME LANDSCAPE IN PANCREATIC CANCER FOR PRECISION MEDICINE
Xu, Y. (2024) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/p0mh-f123
Сигнальный путь Wnt и открытие лекарств. II. Низкомолекулярные ингибиторы Wnt/β-катенинового пути
Степанович, Х. Ю., Zaitsev, S., Tiasto, V., Митяева, А. М., Шодунке, О. К., & Степанович, Б. И. (2026) · Clinical and Fundamental Medicine · doi:10.24866/3033-5485/2026-2/58-100
Zhang, Y., Vinogradov, A. A., Hamada, K., Sun, Y., Sengoku, T., & Suga, H. (2026) · Angewandte Chemie · doi:10.1002/ange.2417165
Wei, Y., Wang, Z., Sun, D., Xing, Z., Yu, H., & Wang, L. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119267
Hamidi, M., Omolo, K. A., Hart, K. W., Sitaram, S., Zhou, Y., & Torres‐Ayuso, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.28.747625
Feasibility of targeting Traf2-and-Nck-Interacting kinase in synovial sarcoma (本文)
Kanda, T. (2021) · Institutional Repositories DataBase (IRDB)
BindingDB (2022) · UC San Diego · doi:10.7270/q2639tbb
BindingDB Entry 50017576: Discovery of 3,4-Dihydrobenzo[
BindingDB (2023) · UC San Diego · doi:10.7270/q2gh9p18
van Os, B. W., Kusters, P. J. H., den Toom, M., Beckers, L., van Tiel, C. M., Vos, W. G., de Jong, E., Kieser, A., van Roomen, C., Binder, C. J., et al. (2023) · doi:10.3389/fcvm.2023.1171764.s006
Chau, K. M., Dominic, A., Davis, E. L., Kotla, S., Berrios, E. T., Fahim, A., Arunesh, A., Li, S., Zhao, D., Chen, K., et al. (2024) · doi:10.3389/fcvm.2023.1213428.s006
Metadata
- Authors
- Masuda, M., Uno, Y., Ohbayashi, N., Ohata, H., Mimata, A., Kukimoto-Niino, M., Moriyama, H., Kashimoto, S., Inoue, T., Goto, N., Okamoto, K., Shirouzu, M., Sawa, M., & Yamada, T.
- Affiliations
- National Cancer Centre Japan (JP)
- Carna Biosciences (Japan) (JP)
- RIKEN (JP)
- National Cancer Center Research Institute (JP)
- Corresponding author
- Yamada, Tesshi
- Venue
- Nature Communications
- Published
- 2016-08-26
- Volume
- 7
- Issue
- 1
- Pages
- 12586-12586
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5007443
- OpenAlex
- W2506489222
- Cited by
- 168
- References
- 65
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 23 · 2023: 17 · 2022: 32 · 2021: 24 · 2020: 16 · 2019: 6 · 2018: 10 · 2017: 9 · 2016: 2
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Japan Agency for Medical Research and Development
- National Institute of Biomedical Innovation
- Japan Society for the Promotion of Science (26293073, 15K14390)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- TNIK, colorectal cancer stem cells, Wnt/β-catenin signaling, small-molecule kinase inhibitors, intestinal tumorigenesis, ApcMin/+ mice, T-cell factor 4, co-crystal structure, colorectal cancer treatment
- MeSH terms
- Germinal Center Kinases, Administration, Oral, Aged, Animals, Azoxymethane, Cell Transformation, Neoplastic, Female, Humans, Imidazoles, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Nude, Middle Aged, Mutation, Protein Binding, Quinazolines, Recombinant Proteins, Neoplastic Stem Cells, Colorectal Neoplasms, Protein Serine-Threonine Kinases, Mice, Knockout, Crystallography, X-Ray, Xenograft Model Antitumor Assays, Adenomatous Polyposis Coli Protein, Ubiquitin-Protein Ligases, Cell Line, Tumor, Protein Kinase Inhibitors, Cell Proliferation, Wnt Proteins, beta Catenin, Mice, Wnt Signaling Pathway, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.